177 related articles for article (PubMed ID: 23119114)
1. Clinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinoma.
Rahmani A; Alzohairy M; Babiker AY; Rizvi MA; Elkarimahmad HG
Int J Clin Exp Pathol; 2012; 5(9):965-71. PubMed ID: 23119114
[TBL] [Abstract][Full Text] [Related]
2. Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx.
Sullu Y; Gun S; Atmaca S; Karagoz F; Kandemir B
Diagn Pathol; 2010 Jun; 5():35. PubMed ID: 20546613
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
4. Metastasis-associated protein 1 expression in oral squamous cell carcinomas: correlation with metastasis and angiogenesis.
Andishehtadbir A; Najvani AD; Pardis S; Ashkavandi ZJ; Ashraf MJ; Khademi B; Kamali F
Turk Patoloji Derg; 2015; 31(1):9-15. PubMed ID: 25301048
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of β2-microglobulin expression in progressive human oral squamous cell carcinoma.
Jiang Q; Patima S; Ye DX; Pan HY; Zhang P; Zhang ZY
Oncol Rep; 2012 Apr; 27(4):1058-64. PubMed ID: 22211248
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evidence of PTEN in oral squamous cell carcinoma and its correlation with the histological malignancy grading system.
Squarize CH; Castilho RM; Santos Pinto D
J Oral Pathol Med; 2002 Aug; 31(7):379-84. PubMed ID: 12224530
[TBL] [Abstract][Full Text] [Related]
7. High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
Moura IM; Delgado ML; Silva PM; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
J Oral Pathol Med; 2014 Mar; 43(3):225-31. PubMed ID: 24044615
[TBL] [Abstract][Full Text] [Related]
8. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
9. Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.
Tripathi SC; Kaur J; Matta A; Gao X; Sun B; Chauhan SS; Thakar A; Shukla NK; Duggal R; Choudhary AR; DattaGupta S; Sharma MC; Ralhan R; Siu KW
Mod Pathol; 2012 Jan; 25(1):14-25. PubMed ID: 22002576
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell Bcl-2 and lymph node metastasis in patients with oral squamous cell carcinoma.
Tarquinio SB; Zhang Z; Neiva KG; Polverini PJ; Nör JE
J Oral Pathol Med; 2012 Feb; 41(2):124-30. PubMed ID: 21936874
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of vascular endothelial growth factors A and C in oral squamous cell carcinoma.
Yanase M; Kato K; Yoshizawa K; Noguchi N; Kitahara H; Nakamura H
J Oral Pathol Med; 2014 Aug; 43(7):514-20. PubMed ID: 24762199
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of PTEN and PI3K/AKT signal transduction pathway in non-small cell lung cancer.
Yun F; Jia Y; Li X; Yuan L; Sun Q; Yu H; Shi L; Yuan H
Int J Clin Exp Pathol; 2013; 6(10):2112-20. PubMed ID: 24133589
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma.
Monteiro LS; Delgado ML; Ricardo S; Garcez F; do Amaral B; Warnakulasuriya S; Lopes C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 May; 115(5):638-45. PubMed ID: 23601218
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
16. PTEN and miR-26b: Promising prognostic biomarkers in initiation and progression of Oral Squamous Cell Carcinoma.
Baghaei F; Abdollahi A; Mohammadpour H; Jahanbin M; Naseri Taheri F; Aminishakib P; Emami Razavi A; Kharazifard M
J Oral Pathol Med; 2019 Jan; 48(1):31-35. PubMed ID: 30372795
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.
Guo Y; Ma Y; Hu X; Song R; Zhu L; Zhong M
Cancer Biol Ther; 2018 Mar; 19(3):205-213. PubMed ID: 29281558
[TBL] [Abstract][Full Text] [Related]
18. Significance of
DE Jesus Oliveira Kato V; DE Abreu MC; DE Brito Kato AM; DE Souza LL; Pontes FSC; DE Castro Sant'anna C; GonÇalves A; Pontes HAR; Khayat AS; Burbano RMR
Anticancer Res; 2020 Nov; 40(11):6355-6366. PubMed ID: 33109573
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance.
Carlos de Vicente J; Herrero-Zapatero A; Fresno MF; López-Arranz JS
Oral Oncol; 2002 Apr; 38(3):301-8. PubMed ID: 11978554
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of glucosylceramide synthase and P-glycoprotein expression in oral cavity cancer.
Kim JW; Park Y; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
Int J Clin Oncol; 2016 Oct; 21(5):883-889. PubMed ID: 27000845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
